More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

Medical Marijuana, Inc.’s HempMeds® Mexico Set Up to Commercialize RSHO-X, the First-Ever CBD Product Available in Mexico, and Other Cannabis Products

Medical Marijuana, Inc.’s HempMeds® Mexico Set Up to Commercialize RSHO-X, the First-Ever CBD Product Available in Mexico, and Other Cannabis Products

by | Apr 6, 2016 | Company News, HempMeds Mexico, Press Releases

In Anticipation of Mexico’s Historic Push Toward Legalization, Medical Marijuana, Inc. Sponsors and Promotes National Education Tour of Events and Completes Four National Debates San Diego, CA — March 30, 2016 – Medical Marijuana, Inc. (OTC PINK: MJNA) is proud...
Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy

by | Feb 22, 2016 | Company News, Kannalife Sciences, Press Releases

Kannalife Sciences, Inc., a Phyto-Medical Company™ has found through its research that KLS-13019 is 50x More Potent and Over 400-Fold Safer Than CBD SAN DIEGO, CA – February 18, 2016 – Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce that the Company’s...
Medical Marijuana, Inc.’s New Cannabidiol (CBD) Hemp Oil, RSHO-X™ From HempMeds®, Featured at Southwest Cannabis Conference in Fort Worth, TX

Medical Marijuana, Inc.’s New Cannabidiol (CBD) Hemp Oil, RSHO-X™ From HempMeds®, Featured at Southwest Cannabis Conference in Fort Worth, TX

by | Feb 22, 2016 | Company News, Dixie Botanicals, HempMeds, Press Releases

Featured Speakers Include MJNA CEO Stuart Titus, Ex-NFL Star Marvin Washington, HempMeds’ CBD Hemp Oil Advocate Penny Howard in Booth 614 & 615 on Feb. 27-28 SAN DIEGO, Feb. 22, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc.’s (OTC Pink:MJNA) HempMeds® is pleased...

Subscribe for Company Updates

* indicates required

Follow us on

social networks

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.